- £257.60m
- £248.40m
- £402.90m
- 59
- 32
- 89
- 66
Annual income statement for Marlowe, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 185 | 192 | 316 | 382 | 403 |
| Cost of Revenue | |||||
| Gross Profit | 76.1 | 83.3 | 139 | 138 | 152 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 183 | 191 | 306 | 380 | 408 |
| Operating Profit | 2.1 | 1 | 9.8 | 2.4 | -5.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.5 | -1.6 | 5.9 | -4.5 | -16.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.4 | -1.7 | 0.7 | -1.7 | -13.7 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.4 | -1.7 | 0.7 | -3.8 | -10.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.4 | -1.7 | 0.7 | -3.8 | -10.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.115 | 0.061 | 0.143 | 0.101 | -0.009 |